Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis
Eli M. Miloslavsky(Massachusetts General Hospital), John H. Stone(Massachusetts General Hospital), Liz Lightstone(Imperial College London), Ray Naden(McMaster University), Murray B. Urowitz(Toronto Western Hospital), Liam G. Heaney(Queen's University Belfast), Paul Brunetta(Pharmaceutical Product Development (United States)), Jeffrey M. Gelfand(University of California, San Francisco), James T. Rosenbaum(Legacy Health), Frank Buttgereit(Humboldt-Universität zu Berlin), Paul Brogan(University College London), J. W. J. Bijlsma, E. Sherwood Brown(The University of Texas Southwestern Medical Center), Jean-Francois Dicaire, Michelle Petri(Johns Hopkins University), Hyon K. Choi(Boston University), Na Lu(Massachusetts General Hospital), Dédée F. Murrell(Sutherland Hospital), Kenneth S. Saag(University of Alabama at Birmingham), Kevin Winthrop(Oregon Health & Science University)
Cited by 231
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
|Annals of the Rheumatic Diseases|2013|1.4k
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
|New England Journal of Medicine|2005|1.1k
Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products
|Journal of Biological Chemistry|2000|957